FRG Family Wealth Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

FRG Family Wealth Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,025	Closed	-$47.2K	–	161
2024 Q1	$47.2K	Buy	+2,025	New	+$60.9K	0.01%	207
2023 Q3	–	Sell	-6,815	Closed	-$232K	–	138
2023 Q2	$232K	Sell	6,815 -650	-9%	-$20.4K	0.05%	127
2023 Q1	$224K	Hold	7,465	–	–	0.05%	135
2022 Q4	$211K	Sell	7,465 -2,982	-29%	-$94.6K	0.05%	135
2022 Q3	$343K	Hold	10,447	–	–	0.08%	112
2022 Q2	$329K	Hold	10,447	–	–	0.08%	117
2022 Q1	$480K	Buy	10,447 +5	+0%	+$238	0.09%	108
2021 Q4	$639K	Sell	10,442 -2,452	-19%	-$170K	0.12%	93
2021 Q3	$963K	Buy	12,894 +105	+0.8%	+$8.81K	0.19%	75
2021 Q2	$1.18M	Buy	12,789 +2,554	+25%	+$217K	0.22%	68
2021 Q1	$908K	Buy	10,235 +4,254	+71%	+$422K	0.18%	76
2020 Q4	$558K	Buy	+5,981	New	+$477K	0.12%	90

Other funds holding ARKG

MMEA

Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

FRG Family Wealth Advisors's ARKG Position: Q2 2024 in Review

FRG Family Wealth Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2024, closing a stake of 2,025 shares — an estimated $47.2K sold.

FRG Family Wealth Advisors first reported a position in ARKG in Q4 2020 and held it in 12 quarters. The position peaked at $1.18M in Q2 2021. 262 funds tracked by Wall St. Rank hold ARKG as of Q2 2024.

FRG Family Wealth Advisors reported no remaining ARK Genomic Revolution ETF position as of Q2 2024 after selling out during the quarter.
FRG Family Wealth Advisors sold 2,025 ARK Genomic Revolution ETF shares in Q2 2024, an estimated $47.2K.
FRG Family Wealth Advisors first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 12 quarters.
FRG Family Wealth Advisors's ARK Genomic Revolution ETF position peaked at $1.18M in Q2 2021.
262 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2024.

Based on FRG Family Wealth Advisors's 13F filing for Q2 2024, filed 7 Aug 2024.